ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
148.27
-0.56 (-0.38%)
At close: Jun 26, 2026, 4:00 PM EDT
148.27
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT

ICU Medical Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for ICU Medical stock have an average target of 165.5, with a low estimate of 163 and a high estimate of 170. The average target predicts an increase of 11.62% from the current stock price of 148.27.

Analyst Consensus: Buy
Target Low Average Median High
Price $163 $165.5 $165 $170
Change +9.93% +11.62% +11.28% +14.66%

Analyst Ratings

The average analyst rating for ICU Medical stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 333334
Buy 233344
Hold 211100
Sell 000000
Strong Sell 000000
Total 777778

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Buy
Initiates
$170
Buy Initiates $170 +14.66% Jun 15, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$163
Buy Maintains $163 +9.93% Jun 10, 2026
Needham
Needham
Buy
Upgrades
$165
Buy Upgrades $165 +11.28% May 27, 2026
KeyBanc
KeyBanc
Buy
Reiterates
$164
Buy Reiterates $164 +10.61% May 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.17B
from 2.23B
Decreased by -2.61%
Revenue Next Year
2.27B
from 2.17B
Increased by 4.51%
EPS This Year
8.16
from 7.76
Increased by 5.12%
EPS Next Year
9.30
from 8.16
Increased by 14.04%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
1.32B2.28B2.26B2.38B2.23B2.17B2.27B
Revenue Growth
3.56%73.21%-0.92%5.44%-6.33%-2.61%4.51%
EPS
4.74-3.11-1.23-4.830.032.763.82
EPS Growth
17.91%----9,196.36%38.20%
Forward PE
-----53.6938.85
No. Analysts -----77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 2.2B 2.3B
Avg 2.2B 2.3B
Low 2.2B 2.2B

Revenue Growth

Revenue Growth 202620272028
High
-2.0%
5.3%
Avg
-2.6%
4.5%
Low
-3.1%
3.4%

EPS Forecast

EPS 202620272028
High 8.20 9.65
Avg 8.16 9.30
Low 8.08 9.09

EPS Growth

EPS Growth 202620272028
High
5.7%
18.3%
Avg
5.1%
14.0%
Low
4.1%
11.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.